Literature DB >> 20635562

Psychometric properties of the portuguese version of the Kansas City cardiomyopathy questionnaire in dilated cardiomyopathy with congestive heart failure.

Elisabete Nave-Leal1, José Pais-Ribeiro, Mario Martins Oliveira, Nogueira Da Silva, Rui Soares, José Fragata, Rui Ferreira.   

Abstract

UNLABELLED: Several studies have shown that patients with congestive heart failure (CHF) have a compromised health-related quality of life (HRQL), and this, in recent years, has become a primary endpoint when considering the impact of treatment of chronic conditions such as CHF.
OBJECTIVES: To evaluate the psychometric properties of the Portuguese version of a new specific instrument to measure HRQL in patients hospitalized for CHF: the Kansas City Cardiomyopathy Questionnaire (KCCQ).
METHODS: The KCCQ was applied to a sample of 193 consecutive patients hospitalized for CHF. Of these, 105 repeated the assessment 3 months after admission, with no events during this period. Mean age was 64.4 +/- 12.4 years (21-88), and 72.5% were 72.5% male. CHF was of ischemic etiology in 4% of cases.
RESULTS: This version of the KCCQ was subjected to statistical validation, with assessment of reliability and validity, similar to the American version. Reliability was assessed by the internal consistency of the domains and summary scores, which showed similar values of Cronbach alpha (0.50-0.94). Validity was assessed by convergence, sensitivity to differences between groups and sensitivity to changes in clinical condition. We evaluated the convergent validity of all domains related to functionality, through the relationship between them and a measure of functionality, the New York Heart Association (NYHA) classification. Significant correlations were found (p < 0.01) for this measure of functionality i patients with CHF. Analysis of variance between the physical limitation domain, the summary scores and NYHA class was performed and statistically significant differences were found (F = 23.4; F = 36.4; F = 37.4, p = 0.0001) in the ability to discriminate severity of clinical condition. A second evaluation was performed on 105 patients at the 3-month follow-up outpatient appointment, and significant changes were observed in the mean scores of the domains assessed between hospital admission and the clinic appointment (differences from 14.9 to 30.6 on a scale of 0-100), indicating that the domains assessed are sensitive to changes in clinical condition. The correlation between dimensions of quality of life in the KCCQ is moderate, suggesting that the dimensions are independent, supporting the multifactorial nature of HRQL and the suitability of this measure for its evaluation.
CONCLUSION: The KCCQ is a valid instrument, sensitive to change and a specific measure of HRQL in a population with dilated cardiomyopathy and CHF.

Entities:  

Mesh:

Year:  2010        PMID: 20635562

Source DB:  PubMed          Journal:  Rev Port Cardiol        ISSN: 0870-2551            Impact factor:   1.374


  3 in total

1.  Psychometric properties of the Kansas City Cardiomyopathy Questionnaire (KCCQ).

Authors:  Ruth Masterson Creber; Rosemary Polomano; John Farrar; Barbara Riegel
Journal:  Eur J Cardiovasc Nurs       Date:  2012-03-28       Impact factor: 3.908

2.  Determination of the longitudinal sensitivity of the AVVQ-Brazil Quality of Life Questionnaire to non-surgical treatment of chronic venous disease.

Authors:  Flávia de Jesus Leal; Renata Cardoso Couto; Guilherme Benjamin Brandão Pitta; Solange Andreoni
Journal:  J Vasc Bras       Date:  2019-11-18

3.  Design of a multifaceted strategy based on automated text messaging in patients with recent heart failure admission.

Authors:  Luis E Rohde; Conrado R Hoffmann Filho; Marciane M Rover; Eneida Rejane Rabelo-Silva; Letícia Lopez; Luiz C S Passos; Odilson M Silvestre; Silvia M Martins; José A de Figueiredo Neto; Fábio S Silveira; Manoel F Canesin; Marcus V Simões; Fábio Akio Nishijuka; Eduardo G Bertoldi; Luiz C Danzmann; Ricardo Mourilhe-Rocha; Ellen Hettwer Magedanz; Mauro Esteves; Fábio M de Castilho; Miguel M Fernandes-Silva; Luiz E F Ritt; Mariana Blacher; Rafael M Soares; Alexandre B Cavalcanti; Felix Ramirez
Journal:  ESC Heart Fail       Date:  2021-09-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.